Preferred Label : Alzheimer disease, familial, 1;
Symbol : AD1;
CISMeF acronym : AD; AD1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Presenile and senile dementia;
Included titles and symbols : Alzheimer disease; Alzheimer disease, early-onset, with cerebral amyloid angiopathy; Alzheimer disease, protection against; AD;
Description : Alzheimer disease is the most common form of progressive dementia in the elderly.
It is a neurodegenerative disorder characterized by the neuropathologic findings of
intracellular neurofibrillary tangles (NFT) and extracellular amyloid plaques that
accumulate in vulnerable brain regions (Sennvik et al., 2000). Terry and Davies (1980)
pointed out that the 'presenile' form, with onset before age 65, is identical to the
most common form of late-onset or 'senile' dementia, and suggested the term 'senile
dementia of the Alzheimer type' (SDAT). Haines (1991) reviewed the genetics of AD.
Selkoe (1996) reviewed the pathophysiology, chromosomal loci, and pathogenetic mechanisms
of Alzheimer disease. Theuns and Van Broeckhoven (2000) reviewed the transcriptional
regulation of the genes involved in Alzheimer disease. - Genetic Heterogeneity of
Alzheimer Disease Alzheimer disease is a genetically heterogeneous disorder. See also
AD2 (104310), associated with the APOE*4 allele (107741) on chromosome 19; AD3 (607822),
caused by mutation in the presenilin-1 gene (PSEN1; 104311) on 14q; and AD4 (606889),
caused by mutation in the PSEN2 gene (600759) on 1q31. There is evidence for additional
AD loci on other chromosomes; see AD5 (602096) on 12p11, AD6 (605526) on 10q24, AD7
(606187) on 10p13, AD8 (607116) on 20p, AD9 (608907) on 19p13, AD10 (609636) on 7q36,
AD11 (609790) on 9q22, AD12 (611073) on 8p12-q22, AD13 (611152) on 1q21, AD14 (611154)
on 1q25, AD15 (611155) on 3q22-q24, AD16 (300756) on Xq21.3, AD17 (615080) on 6p21.2,
and AD18 (615590), associated with variation in the ADAM10 gene (602192) on 15q21.
Evidence also suggests that mitochondrial DNA polymorphisms may be risk factors in
Alzheimer disease (502500). Finally, there have been associations between AD and various
polymorphisms in other genes, including alpha-2-macroglobulin (A2M; 103950.0005),
low density lipoprotein-related protein-1 (LRP1; 107770), the transferrin gene (TF;
190000), the hemochromatosis gene (HFE; 613609), the NOS3 gene (163729), the vascular
endothelial growth factor gene (VEGF; 192240), the ABCA2 gene (600047), and the TNF
gene (191160) (see MOLECULAR GENETICS).;
Inheritance : Autosomal dominant;
Molecular basis : Susceptibility conferred by mutation in the alpha-2-macroglobulin gene (A2M, 103950.0005); Caused by mutation in the amyloid beta (A4) precursor protein gene (APP, 104760.0002);
Prefixed ID : #104300;
Origin ID : 104300;
UMLS CUI : C1863052;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
False automatic mappings
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT